Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.6 CHF | +2.13% | -2.74% | -2.14% |
04-25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
04-25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.14% | 98.71M | |
+18.88% | 80.5B | |
+14.11% | 9.15B | |
-14.14% | 4.9B | |
+43.39% | 4.49B | |
+18.90% | 4.44B | |
+7.93% | 2.19B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals : Completes First Six-Month Period in Mid-Stage Trial For Duchenne Muscular Dystrophy Drug